{"id":810150,"date":"2025-02-06T16:29:20","date_gmt":"2025-02-06T21:29:20","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-present-at-upcoming-investor-conferences\/"},"modified":"2025-02-06T16:29:20","modified_gmt":"2025-02-06T21:29:20","slug":"mannkind-to-present-at-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-present-at-upcoming-investor-conferences\/","title":{"rendered":"MannKind to Present at Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">DANBURY, Conn.\u00a0and\u00a0WESTLAKE VILLAGE, Calif., Feb.  06, 2025  (GLOBE NEWSWIRE) &#8212; <strong>MannKind Corporation\u00a0(Nasdaq: MNKD)<\/strong>, a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced its participation at three investor conferences during the first quarter of 2025. MannKind\u2019s Chief Executive Officer Michael Castagna, PharmD, and Chief Financial Officer\u00a0Chris Prentiss\u00a0will share updates during the following investor conferences:<\/p>\n<p>\n        <strong>Oppenheimer 35<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Healthcare Life Sciences Conference (virtual)<\/strong><br \/>\n        <br \/>Tuesday, February 11, 11:20 a.m. ET<\/p>\n<p>\n        <strong>Leerink Partners 2025 Global Healthcare Conference in Miami<\/strong><br \/>\n        <br \/>Tuesday, March 11, 8:40 a.m. ET<\/p>\n<p>\n        <strong>Barclays 27<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Global Healthcare Conference in Miami<\/strong><br \/>\n        <br \/>March 12, 1:30 p.m. ET<\/p>\n<p>Links to the live audio webcast of the sessions will be available on MannKind Corporation\u2019s website at:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8gUD5I1OkfczLOrYMVXTAxZ3uxQNUUHnaK1QvNWGBzYlz8Z5sW6tqHru6c-AvhcPONLTMXOfYVO0JBsVPKoRjkfVvh0uQjD8k23s8xfosCL6HSQAgm0_nl3nxJdepIQFzWSmqM1LOWyg1ARMldB9H0Iwqm-dJtOTxz3SaJwV1i5Q54HYm6R8DEzQYSnquhDZYeZlUgxu6MmSO0NZgVTEMM2VR_dNSFGdhkPrtYZf6-dLNJVwzUx-RVwaC4AyrqGQ9TA9BcHRDgbt6XDKJl6y0PZmys343vriAQVWRSGN5VDEiWm5qvdX8Iv27K-BfTeKbyF09y6Uekj6e1yAZCGnXuFHjGMPelJXRKJhxcC09Mw55-JK04dYxWbB_k_IddZwUWTGFp2-u1RXT5UGBc97eUvFi8i70InHMlxpK2Q4Xbc=\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.mannkindcorp.com\/events-and-presentations<\/a>. Recorded versions will also be available on the website for approximately 90 days following the conference.<\/p>\n<p>\n        <strong>About MannKind<\/strong><br \/>\n        <br \/>MannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of innovative inhaled therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases.<\/p>\n<p>We are committed to using our formulation capabilities and device engineering prowess to lessen the burden of diseases such as diabetes, nontuberculous mycobacterial (NTM) lung disease, pulmonary fibrosis, and pulmonary hypertension.\u00a0Our signature technologies \u2013 dry-powder formulations and inhalation devices \u2013 offer rapid and convenient delivery of medicines to the deep lung where they can exert an effect locally or enter the systemic circulation, depending on the target indication.<\/p>\n<p>With a passionate team of Mannitarians collaborating nationwide, we are on a mission to give people control of their health and the freedom to live life.<\/p>\n<p>Please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zVLgyvApGJZ30ghcBwGQzbxSbzVpkEkkT57VMWzg_FivrWhCztK70j3phVtoAV37t1jx99Cc7xnwH6taeKi2uDGH0vIyCNc4olMLdCQAdck=\" rel=\"nofollow\" target=\"_blank\">mannkindcorp.com<\/a> to learn more, and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bTx2lgV7ozC9Xb1R0tlT0voibtMEXr_FIJJFOEZE3-7ZfLz0t9A91Cf87offYcy9wf_70Xe4R-EsflnarQ5YAd_6H5L15oXUiF2LC5FmZeV-Ob6PoUSDQWPTpVbsIw2E\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hS52Z0Pkxwna3ThG_ZizHwrVntWC5Gaef2ZPAyQg4zPU1Hf0Ce56mpbScchnsyyfSvwiIKh5toU6mz7GSpeIedi6qd0Scq1gERFcPcWjTgc=\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0U2aBQWHqsqQofPup_w7XDi_eJD-0pDPsuEKefGawXOPzoWvCv2aZ7uuSzdidgThkM_MytuSSNV4lygBvsNeMw==\" rel=\"nofollow\" target=\"_blank\">X<\/a> or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cTl1PtZJA6wzngKoP4fvu2lpRtXSYW4BpvHu78urijDfRPBYD7ByP4GgowjjACxfteg4BHpe32Bvy4QdFezDuYWBd-jm7c2mnFqlznZdOAI=\" rel=\"nofollow\" target=\"_blank\">Instagram<\/a>.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzkxMSM2NzM4MzM5IzIwMDgxMDc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NzhhY2VkMTQtYmUzMC00M2VmLTkwZDUtNzJmYzRmN2FmMWVhLTEwMTk2ODA=\/tiny\/MannKind.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>For MannKind:\r\nInvestor Relations\r\nAna Kapor\r\n(818) 661-5000\r\nEmail: ir@mnkd.com\r\n\r\nMedia Relations\r\nChristie Iacangelo\r\n(818) 292-3500\r\nEmail: media@mnkd.com<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>DANBURY, Conn.\u00a0and\u00a0WESTLAKE VILLAGE, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) &#8212; MannKind Corporation\u00a0(Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced its participation at three investor conferences during the first quarter of 2025. MannKind\u2019s Chief Executive Officer Michael Castagna, PharmD, and Chief Financial Officer\u00a0Chris Prentiss\u00a0will share updates during the following investor conferences: Oppenheimer 35 th Annual Healthcare Life Sciences Conference (virtual) Tuesday, February 11, 11:20 a.m. ET Leerink Partners 2025 Global Healthcare Conference in Miami Tuesday, March 11, 8:40 a.m. ET Barclays 27 th Annual Global Healthcare Conference in Miami March 12, 1:30 p.m. ET Links to the live audio webcast of the sessions &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-present-at-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;MannKind to Present at Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-810150","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MannKind to Present at Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-present-at-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MannKind to Present at Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"DANBURY, Conn.\u00a0and\u00a0WESTLAKE VILLAGE, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) &#8212; MannKind Corporation\u00a0(Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced its participation at three investor conferences during the first quarter of 2025. MannKind\u2019s Chief Executive Officer Michael Castagna, PharmD, and Chief Financial Officer\u00a0Chris Prentiss\u00a0will share updates during the following investor conferences: Oppenheimer 35 th Annual Healthcare Life Sciences Conference (virtual) Tuesday, February 11, 11:20 a.m. ET Leerink Partners 2025 Global Healthcare Conference in Miami Tuesday, March 11, 8:40 a.m. ET Barclays 27 th Annual Global Healthcare Conference in Miami March 12, 1:30 p.m. ET Links to the live audio webcast of the sessions &hellip; Continue reading &quot;MannKind to Present at Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-present-at-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-06T21:29:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzkxMSM2NzM4MzM5IzIwMDgxMDc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-to-present-at-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-to-present-at-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"MannKind to Present at Upcoming Investor Conferences\",\"datePublished\":\"2025-02-06T21:29:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-to-present-at-upcoming-investor-conferences\\\/\"},\"wordCount\":296,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-to-present-at-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MzkxMSM2NzM4MzM5IzIwMDgxMDc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-to-present-at-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-to-present-at-upcoming-investor-conferences\\\/\",\"name\":\"MannKind to Present at Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-to-present-at-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-to-present-at-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MzkxMSM2NzM4MzM5IzIwMDgxMDc=\",\"datePublished\":\"2025-02-06T21:29:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-to-present-at-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-to-present-at-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-to-present-at-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MzkxMSM2NzM4MzM5IzIwMDgxMDc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MzkxMSM2NzM4MzM5IzIwMDgxMDc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-to-present-at-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MannKind to Present at Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MannKind to Present at Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-present-at-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"MannKind to Present at Upcoming Investor Conferences - Market Newsdesk","og_description":"DANBURY, Conn.\u00a0and\u00a0WESTLAKE VILLAGE, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) &#8212; MannKind Corporation\u00a0(Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced its participation at three investor conferences during the first quarter of 2025. MannKind\u2019s Chief Executive Officer Michael Castagna, PharmD, and Chief Financial Officer\u00a0Chris Prentiss\u00a0will share updates during the following investor conferences: Oppenheimer 35 th Annual Healthcare Life Sciences Conference (virtual) Tuesday, February 11, 11:20 a.m. ET Leerink Partners 2025 Global Healthcare Conference in Miami Tuesday, March 11, 8:40 a.m. ET Barclays 27 th Annual Global Healthcare Conference in Miami March 12, 1:30 p.m. ET Links to the live audio webcast of the sessions &hellip; Continue reading \"MannKind to Present at Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-present-at-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-06T21:29:20+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzkxMSM2NzM4MzM5IzIwMDgxMDc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-present-at-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-present-at-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"MannKind to Present at Upcoming Investor Conferences","datePublished":"2025-02-06T21:29:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-present-at-upcoming-investor-conferences\/"},"wordCount":296,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-present-at-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzkxMSM2NzM4MzM5IzIwMDgxMDc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-present-at-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-present-at-upcoming-investor-conferences\/","name":"MannKind to Present at Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-present-at-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-present-at-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzkxMSM2NzM4MzM5IzIwMDgxMDc=","datePublished":"2025-02-06T21:29:20+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-present-at-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-present-at-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-present-at-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzkxMSM2NzM4MzM5IzIwMDgxMDc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzkxMSM2NzM4MzM5IzIwMDgxMDc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-present-at-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"MannKind to Present at Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/810150","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=810150"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/810150\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=810150"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=810150"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=810150"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}